<?xml version="1.0" encoding="UTF-8"?>
<ref id="R26">
 <label>26.</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fatkenheuer</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Nelson</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Lazzarin</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Konourina</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Hoepelman</surname>
   <given-names>AI</given-names>
  </name>, 
  <name>
   <surname>Lampiris</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Hirschel</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Tebas</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Raffi</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Trottier</surname>
   <given-names>B</given-names>
  </name>
  <etal/>: 
  <article-title>Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection</article-title>. 
  <source>N Engl J Med</source>
  <year>2008</year>, 
  <volume>359</volume>:
  <fpage>1442</fpage>â€“
  <lpage>1455</lpage>.
  <pub-id pub-id-type="pmid">18832245</pub-id>
 </mixed-citation>
</ref>
